Lv4
460 积分 2023-05-12 加入
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
7天前
已完结
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial
10天前
已完结
Metastasis prevention with bone-targeted agents: a complex interaction between the microenvironment and tumour biology
16天前
已完结
Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy‐proven node‐positive breast cancer: A prospective study
2个月前
已完结
The predictive value of DKI in breast cancer: Does tumour subtype affect pathological response evaluations?
2个月前
已完结
Comparing Multi–b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
2个月前
已完结
Selective Elimination of Breast Surgery for Invasive Breast Cancer
4个月前
已完结
Predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients based on ultrasound longitudinal temporal depth network fusion model
4个月前
已完结
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
4个月前
已完结
Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
4个月前
已完结
皖公网安备34019202002308
